Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.42M Sell
18,816
-11,487
-38% -$1.34M 0.01% 478
2026
Q1
$3.65M Buy
30,303
+10,219
+51% +$1.18M 0.02% 336
2025
Q4
$2.11M Buy
20,084
+7,900
+65% +$742K 0.01% 472
2025
Q3
$1.02M Buy
12,184
+1,106
+10% +$91.1K ﹤0.01% 552
2025
Q2
$877K Sell
11,078
-5,568
-33% -$443K ﹤0.01% 557
2025
Q1
$1.49M Sell
16,646
-18,154
-52% -$1.69M 0.01% 494
2024
Q4
$3.46M Buy
34,800
+7,319
+27% +$755K 0.02% 305
2024
Q3
$3.12M Sell
27,481
-20,100
-42% -$2.39M 0.02% 416
2024
Q2
$5.89M Buy
47,581
+607
+1% +$78.2K 0.03% 253
2024
Q1
$6.2M Sell
46,974
-9,157
-16% -$1.13M 0.03% 257
2023
Q4
$6.12M Buy
56,131
+3,119
+6% +$324K 0.04% 253
2023
Q3
$5.46M Sell
53,012
-5,557
-9% -$599K 0.04% 241
2023
Q2
$6.76M Sell
58,569
-16,039
-21% -$1.82M 0.05% 222
2023
Q1
$7.94M Sell
74,608
-1,185
-2% -$128K 0.05% 222
2022
Q4
$8.41M Buy
+75,793
New +$7.75M 0.06% 211

Other funds holding MRK

AGF Management's MRK Position: Q2 2026 in Review

AGF Management reduced its Merck (MRK) stake by 38% in Q2 2026, selling an estimated $1.34M and leaving 18,816 shares worth $2.42M. The position accounts for 0.01% of the portfolio, ranked #478.

AGF Management first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.41M in Q4 2022. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • AGF Management held 18,816 shares of Merck worth $2.42M as of Q2 2026.
  • AGF Management sold 11,487 Merck shares in Q2 2026, an estimated $1.34M.
  • Merck made up 0.01% of AGF Management's portfolio in Q2 2026, its #478 holding.
  • AGF Management first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • AGF Management's Merck position peaked at $8.41M in Q4 2022.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on AGF Management's 13F filing for Q2 2026, filed 10 Aug 2026.